Class ITerminatedD-0557-2022
Drug recall · February 16, 2022
MegMan Performance Booster recall
Why: Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88
- Lots / codes
Lot # 2010291, Exp 01/07/2024
- Quantity
- 750 cartons
- Company
- Junp Hydration LLC, Brooklyn, NY
- Distribution
- Product was distributed nationwide in the USA via Amazon Marketplace
- Initiated
- February 4, 2022 · Voluntary: Firm initiated
- Classified
- February 11, 2022
- Reported
- February 16, 2022
- Ended
- June 9, 2022
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.